US court overturns alpha-amylase enzyme ruling in Novozymes-Danisco battle

In Wisconsin, a federal district court judge has found in favor of Danisco in an on-going dispute between it and Novozymes regarding the patent on an alpha-amylase enzyme.

The judge overturned a last October’s ruling and $18.2 million in damages in favor of Novozymes, saying the patent had an inadequate written description.